Chronic pain in Machado-Joseph disease: a frequent and disabling symptom

Archives of Neurology

Volumn 64, Issue 12, 2007, Pages 1767-1770

  França Jr , Marcondes C ^a   D'Abreu, Anelyssa ^a   Friedman, Joseph H ^b,c   Nucci, Anamarli ^a   Lopes Cendes, Iscia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NeuroHealth   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATAXIA; CHRONIC PAIN; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LEG PAIN; LOW BACK PAIN; MACHADO JOSEPH DISEASE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; PAIN ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOMATOLOGY; TANDEM REPEAT; VISUAL ANALOG SCALE;

ADULT; AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; REPETITIVE SEQUENCES, NUCLEIC ACID; SEX FACTORS;

EID: 37149055805     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.12.1767     Document Type: Article

References (19)

1. Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 2004;3(5):291-304.
2. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet. 1994;8(3):221-228.
3. Coutinho P. Doença de Machado-Joseph: Estudo Clínico, Patológico e Epidemiológico de uma Doença Neurológica de Origem Portuguesa. Porto, Portugal: Tipografia Nunes Ltda; 1994.
4. Løkkegaard T, Nielsen JE, Hasholt L, et al. Machado-Joseph disease in three Scandinavian families. J Neurol Sci. 1998;156(2):152-157.
5. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord. 1986;1(1):45-49.
6. Tinazzi M, Del Vesco C, Fincati E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006;77(7):822-825.
7. Tison F, Wenning GK, Volonte MA, Poewe WR, Henry P, Quinn NP. Pain in multiple system atrophy. J Neurol. 1996;243(2):153-156.
8. Ben Smail D, Jacq C, Denys P, Bussel B. Intrathecal baclofen in the treatment of painful, disabling spasms in Friedreich's ataxia. Mov Disord. 2005;20(6):758-759.
9. Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354(9178):581-585.
10. Trouillas P, Takayanagi T, Hallett M, et al; Ataxia Neuropharmacology Committee of the World Federation of Neurology. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997;145(2):205-211.
11. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540-545.
12. Almeida OP, Almeida SA. Reliability of the Brazilian version of the ++abbreviated form of Geriatric Depression Scale (GDS) short form [in Portuguese]. Arq Neuropsiquiatr. 1999;57(2B):421-426.
13. Nutt JG, Carter JH. Sensory symptoms in parkinsonism related to central dopaminergic function. Lancet. 1984;2(8400):456-457.
14. Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord. 2005;20(12):1557-1563.
15. Koller WC. Sensory symptoms in Parkinson's disease. Neurology. 1984;34(7):957-959.
16. Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5(3):235-245.
17. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;66(4):431-435.
18. n. Arch Neurol. 2001;58(6):899-904.
19. Yamamoto M, Kachi T, Sobue G. Pain-related and electrically stimulated somatosensory evoked potentials in patients with Machado-Joseph disease and multiple system atrophy. Intern Med. 1997;36(8):550-555.